Spirocyclic Cycloalkyne Derivative for Single-Isomer SPAAC
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
There is a need for a new substrate for strain-promoted azide alkyne cycloaddition (SPAAC) that can effectively conjugate a carrier peptide with a payload in peptide-drug conjugates.
Innovation Solution
A novel cycloalkyne derivative with a spiro ring structure is developed, which serves as a substrate for SPAAC, allowing for the conjugation of functional molecules such as pharmacologically active compounds, label compounds, peptides, proteins, and nucleic acids.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Ease of manufacture
If conventional SPAAC substrates are used, then the reaction can proceed without metal catalyst, but the purification becomes difficult due to formation of multiple isomers
Solution Approach 1:
The patent introduces asymmetric substitution patterns on the cycloalkyne ring system, specifically using different substituents at different positions (e.g., R1, R2, R3, R4 can be different groups including aryl, heteroaryl, alkyl, etc.). This asymmetry in molecular structure leads to preferential formation of a single regioisomer during the SPAAC reaction with azides, thereby simplifying purification procedures.
Solution Approach 2:
The patent modifies key parameters of the cycloalkyne substrate including ring size (8-12 membered rings), substitution patterns, and electronic properties of substituents. These parameter changes are designed to control the stereochemistry of the reaction, ensuring formation of a single dominant isomer that is easier to purify while maintaining high reaction efficiency.
2Adaptability or versatility
If diverse functional molecules are conjugated, then the versatility of the substrate increases, but the complexity of the conjugation process increases
Solution Approach 1:
The patent designs the cycloalkyne substrate with universal applicability by incorporating functional groups and substitution patterns that can accommodate various functional molecules including peptides, proteins, nucleic acids, and small molecules. The spirocyclic structure with adjustable substituents (R1-R4) allows the same core substrate to serve multiple conjugation purposes without requiring different substrate designs.
Solution Approach 2:
The patent segments the molecular structure into a stable core spirocyclic cycloalkyne framework and variable peripheral substituents. This segmentation allows the core structure to provide consistent reactive properties for SPAAC while the peripheral substituents can be tailored for specific applications, simplifying the overall conjugation process by separating universal and specific functions.
3Productivity
If the cycloalkyne structure is optimized for SPAAC reactivity, then the reaction efficiency improves, but the stability of the compound may be compromised
Solution Approach 1:
The patent applies local quality by creating a spirocyclic structure where the cycloalkyne unit is embedded within a larger rigid spiro framework. This local structural modification concentrates the reactive character at the alkyne position while the surrounding spiro structure provides overall molecular stability and structural integrity, allowing high reactivity without compromising compound stability.
Solution Approach 2:
The patent incorporates stable spirocyclic frameworks and carefully selected substituents that provide structural cushioning before the reaction occurs. The rigid spiro structure pre-organizes the molecule and provides steric and electronic protection that maintains compound stability while allowing the alkyne position to remain highly reactive toward azides.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The cycloalkyne derivative is highly universal for SPAAC and facilitates the production of peptide-drug conjugates, offering efficient conjugation and ease of purification due to the formation of a single regioisomer of a 1,2,3-triazole ring.
Implementation Method 1
a strain-promoted azide alkyne cycloaddition (SPAAC) has been developed and has been gaining attention; this reaction activates an alkyne molecule without using a metal catalyst, enabling it to react with an azide compound
Data Source
Figure 1~2
Figure 3
Figure 4
AI summary
The present invention provides a novel strain-promoted azide alkyne cycloaddition (SPAAC). The present invention provides a novel cycloalkyne derivative having a spiro ring, as a cycloalkyne derivative that can be used for SPAAC. The present invention also provides a method for producing a conjugate of functional molecules by using the cycloalkyne derivative.